Dakota Wealth Management

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1631353 PALM BEACH GARDENS, FL

Position in REGN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$914,109

-$744,749 QoQ

Shares Held

1,466

-31.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#663

of 1,322 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Dakota Wealth Management holds $7,339,875 across 7 Biotechnology names. REGN ranks #4 (12.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CORT	Corcept Therapeutics Inc	30,200	$2,625,890
2	EXEL	Exelixis, Inc.	31,025	$1,688,070
3	VRTX	Vertex Pharmaceuticals Inc / Ma	2,862	$1,421,641
4	REGN	Regeneron Pharmaceuticals, Inc. This page	1,466	$914,109
5	HALO	Halozyme Therapeutics, Inc.	7,592	$594,225
6	ANVS	Annovis Bio, Inc.	29,000	$53,940
7	ANIX	Anixa Biosciences Inc	15,000	$42,000

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$914,109	1,466	-31.7%	Shares	Defined	2026-08-07
2026-03-31	$1,658,858	2,147	-31.3%	Shares	Defined	2026-05-07
2025-12-31	$2,412,865	3,126	+122.0%	Shares	Defined	2026-01-13
2025-09-30	$791,676	1,408	+2.0%	Shares	Defined	2025-11-10
2025-06-30	$724,500	1,380	+1.0%	Shares	Defined	2025-07-16
2025-03-31	$866,992	1,367	+0.1%	Shares	Defined	2025-05-02
2024-12-31	$973,042	1,366	+2.9%	Shares	Sole	2025-01-17
2024-09-30	$1,394,995	1,327	-4.8%	Shares	Defined	2024-10-23
2024-06-30	$1,465,135	1,394	+1.6%	Shares	Defined	2024-07-22
2024-03-31	$1,320,536	1,372	+226.7%	Shares	Sole	2024-04-24
2020-12-31	$202,905	420	-3.2%	Shares	Other	2021-02-12
2020-09-30	$242,944	434	-0.2%	Shares	Other	2020-11-04
2020-06-30	$271,287	435	-20.8%	Shares	Sole	2020-08-07
2020-03-31	$268,070	549	—	Shares	Other	2020-04-29
No filing history on record for this holder in this stock.